World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
64
Citations
15099
World Ranking
2930
National Ranking
68

Andrés Finzi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrés Finzi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 314 publications — 67th percentile

67% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Andrés Finzi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrés Finzi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 64 D-Index — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Andrés Finzi is affiliated with the University of Montreal in Canada and has an extensive research portfolio primarily centered in Medicine and Immunology and Microbiology. Their work includes significant contributions to the fields of Infectious Diseases, Immunology, Virology, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The main research topics Andrés Finzi has focused on comprise:

  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • COVID-19 Clinical Research Studies
  • Immune Cell Function and Interaction
  • SARS-CoV-2 detection and testing
  • HIV/AIDS drug development and treatment
  • Monoclonal and Polyclonal Antibodies Research

Several recent papers highlight the scope and collaboration in Andrés Finzi's work:

  • "mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection," 2021, Science
  • "Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial," 2021, Nature Medicine
  • "Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike," 2020, Cell Reports Medicine
  • "Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles," 2020, Cell Host & Microbe
  • "Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission," 2022, Nature Microbiology

Andrés Finzi frequently collaborates with several researchers, including:

  • Jonathan Richard
  • Jérémie Prévost
  • Halima Medjahed
  • Guillaume Beaudoin-Bussières
  • Mehdi Benlarbi

Their publications are frequently featured in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Virology
  • Viruses
  • mBio
  • Cell Reports

Best Publications

  • Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.

    Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang

  • mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.

    Leonidas Stamatatos;Leonidas Stamatatos;Julie Czartoski;Yu Hsin Wan;Leah J. Homad

  • Interaction with Cellular CD4 Exposes HIV-1 Envelope Epitopes Targeted by Antibody-Dependent Cell-Mediated Cytotoxicity

    Maxime Veillette;Anik Désormeaux;Halima Medjahed;Nour-Elhouda Gharsallah

  • Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission

    Unknown

  • Unliganded HIV-1 gp120 core structures assume the CD4-bound conformation with regulation by quaternary interactions and variable loops

    Young Do Kwon;Andrés Finzi;Xueling Wu;Cajetan Dogo-Isonagie

  • Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.

    Philippe Bégin;Jeannie Callum;Erin Jamula;Richard Cook

  • HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.

    Jean-Philippe Belzile;Ghislaine Duisit;Nicole Rougeau;Johanne Mercier

  • Topological Layers in the HIV-1 gp120 Inner Domain Regulate gp41 Interaction and CD4-Triggered Conformational Transitions

    Andrés Finzi;Shi Hua Xiang;Beatriz Pacheco;Liping Wang

  • A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

    Unknown

  • The HIV-1 gp120 CD4-Bound Conformation Is Preferentially Targeted by Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies in Sera from HIV-1-Infected Individuals

    Maxime Veillette;Mathieu Coutu;Jonathan Richard;Laurie-Anne Batraville

  • Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles.

    Maolin Lu;Pradeep D. Uchil;Wenwei Li;Desheng Zheng

  • Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals.

    Guillaume Beaudoin-Bussières;Annemarie Laumaea;Sai Priya Anand;Jérémie Prévost

  • Single-Cell Characterization of Viral Translation-Competent Reservoirs in HIV-Infected Individuals

    Amy E. Baxter;Julia Niessl;Rémi Fromentin;Jonathan Richard

  • Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike.

    Jérémie Prévost;Romain Gasser;Guillaume Beaudoin-Bussières;Jonathan Richard

  • Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy.

    Irfan Ullah;Jérémie Prévost;Mark S. Ladinsky;Helen Stone

  • Associating HIV-1 envelope glycoprotein structures with states on the virus observed by smFRET

    Maolin Lu;Xiaochu Ma;Luis R. Castillo-Menendez;Jason Gorman

  • A B-Box 2 Surface Patch Important for TRIM5α Self-Association, Capsid Binding Avidity, and Retrovirus Restriction

    Felipe Diaz-Griffero;Xu Rong Qin;Fumiaki Hayashi;Takanori Kigawa

  • Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.

    Sai Priya Anand;Jérémie Prévost;Manon Nayrac;Guillaume Beaudoin-Bussières

  • Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.

    Toshana L. Foster;Harry Wilson;Shilpa S. Iyer;Karen Coss

  • A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.

    Alexandra Tauzin;Manon Nayrac;Mehdi Benlarbi;Shang Yu Gong

  • Macrophage Infection via Selective Capture of HIV-1-Infected CD4+ T Cells

    Amy E. Baxter;Amy E. Baxter;Rebecca A. Russell;Christopher J.A. Duncan;Michael D. Moore

  • Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike

    Jérémie Prévost;Romain Gasser;Guillaume Beaudoin-Bussières;Jonathan Richard

Frequent Co-Authors

Jonathan Richard
Jonathan Richard University of Montreal
Joseph Sodroski
Joseph Sodroski Harvard Medical School
Daniel Kaufmann
Daniel Kaufmann University of Lausanne
Amos B. Smith
Amos B. Smith University of Pennsylvania
Beatrice H. Hahn
Beatrice H. Hahn University of Pennsylvania
Peter D. Kwong
Peter D. Kwong Columbia University Medical Center
Leonidas Stamatatos
Leonidas Stamatatos Fred Hutchinson Cancer Research Center
George K. Lewis
George K. Lewis University of Maryland, Baltimore
Walther Mothes
Walther Mothes Yale University
Marie Pancera
Marie Pancera Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in advancing their careers within healthcare, there are several related online degrees that complement a background in Immunology. Programs like 12-month accelerated nursing programs offer a fast track to becoming a registered nurse, ideal for those seeking to enter clinical practice quickly.

If you prefer starting your nursing journey with more hands-on experience, many students consider the fastest and easiest LPN programs. These programs provide essential practical skills and lay a foundation for further education.

For professionals aiming to expand their scope of practice, nurse practitioner programs with easy admission are attractive options. These programs often feature flexible online formats, making them accessible to working adults.

Specializing further, especially in mental health, can be pursued through top online PMHNP programs, which offer strong clinical placement rates and are designed to equip students for psychiatric-mental health nursing practice.

Best Scientists Citing Andrés Finzi

Trending Scientists

Recently Published Articles